| answer text |
<p>Since February 2024, all prisoners subject to mandatory drug testing in prisons
have been tested for fentanyl, a potent synthetic opioid. We are working closely with
our contracted drug testing provider to further improve our capabilities to test prisoners
for other synthetic opioids, including nitazenes.</p><p> </p><p>Forensic testing of
suspected drug finds was made available to all public sector prisons in April 2023.
Our contracted forensic analysis provider has capability to detect synthetic opioids
including all fentanyls and nitazenes.</p><p> </p><p>All prisons have a zero-tolerance
approach to drugs and we are aware of the threat synthetic drugs present. Our current
assessment is that there is a low prevalence of Nitazenes in prison custody. However,
we are alert to the risks and continue to monitor this.</p><p> </p><p>Our £100 million
investment in tough security measures, such as X-ray body scanners, is helping tackle
the supply of illicit drugs into prisons.</p><p> </p><p>To prevent the smuggling of
drugs through the mail, we have also invested in next-generation drug trace detection
machines. As of March 2024, every public sector prison now has this cutting-edge technology.</p>
|
|
